CNS Penetration of Teicoplanin in the Treatment of CNS Infections

Pharmacokinetic Profile and Clinical Implications

• Vancomycin, as recommended by the Infectious Diseases Society of America, has a CSF penetration of 1-5% and concentrations of 2-6 μg/mL, making it a guideline-recommended first-line agent for MRSA CNS infections 1
• Linezolid is superior for CNS infections with 66% CSF penetration and levels of 7-10 μg/mL, making it a preferred alternative when IV therapy alone is used 1, 2

Treatment Approach and Critical Pitfalls

• The Infectious Diseases Society of America recommends that surgical intervention, such as shunt removal or abscess drainage, must be performed whenever possible, as antimicrobial therapy alone has poor outcomes for device-related CNS infections 1, 3
• The combination of IV teicoplanin with rifampin, which achieves 22% CSF penetration, may improve outcomes but still requires consideration of alternative agents 1